Eintrag weiter verarbeiten
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases
Gespeichert in:
| Zeitschriftentitel: | The Journal of Neuroscience |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , |
| In: | The Journal of Neuroscience, 35, 2015, 37, S. 12766-12778 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Society for Neuroscience
|
| Schlagwörter: |
| author_facet |
Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. |
|---|---|
| author |
Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. |
| spellingShingle |
Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. The Journal of Neuroscience Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases General Neuroscience |
| author_sort |
brkic, marjana |
| spelling |
Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. 0270-6474 1529-2401 Society for Neuroscience General Neuroscience http://dx.doi.org/10.1523/jneurosci.0006-15.2015 <jats:p>The blood–CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable molecules and pathogens into the brain. Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain. Recent research shows that Alzheimer's disease is associated with morphological changes in CPE cells and compromised production of CSF. Here, we studied the direct effects of Aβ on the functionality of the BCSFB. Intracerebroventricular injection of Aβ1–42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF. It also rapidly affected CPE cell morphology and tight junction protein levels. These changes were associated with loss of BCSFB integrity, as shown by an increase in BCSFB leakage. Aβ1–42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF. Interestingly, BCSFB disruption induced by Aβ1–42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice. These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1–42 oligomers. Our results reveal that Alzheimer's disease-associated soluble Aβ1–42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</jats:p><jats:p><jats:bold>SIGNIFICANCE STATEMENT</jats:bold>No treatments are yet available to cure Alzheimer's disease; however, soluble Aβ oligomers are believed to play a crucial role in the neuroinflammation that is observed in this disease. Here, we studied the effect of Aβ oligomers on the often neglected barrier between blood and brain, called the blood–CSF barrier (BCSFB). This BCSFB is formed by the choroid plexus epithelial cells and is important in maintaining brain homeostasis. We observed Aβ oligomer-induced changes in morphology and loss of BCSFB integrity that might play a role in Alzheimer's disease progression. Strikingly, both inhibition of matrix metalloproteinase (MMP) activity and MMP3 deficiency could protect against the detrimental effects of Aβ oligomer. Clearly, our results suggest that MMP inhibition might have therapeutic potential.</jats:p> Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases The Journal of Neuroscience |
| doi_str_mv |
10.1523/jneurosci.0006-15.2015 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMDAwNi0xNS4yMDE1 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMDAwNi0xNS4yMDE1 |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Society for Neuroscience, 2015 |
| imprint_str_mv |
Society for Neuroscience, 2015 |
| issn |
0270-6474 1529-2401 |
| issn_str_mv |
0270-6474 1529-2401 |
| language |
English |
| mega_collection |
Society for Neuroscience (CrossRef) |
| match_str |
brkic2015amyloidboligomersdisruptbloodcsfbarrierintegritybyactivatingmatrixmetalloproteinases |
| publishDateSort |
2015 |
| publisher |
Society for Neuroscience |
| recordtype |
ai |
| record_format |
ai |
| series |
The Journal of Neuroscience |
| source_id |
49 |
| title |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_unstemmed |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_full |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_fullStr |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_full_unstemmed |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_short |
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_sort |
amyloid β oligomers disrupt blood–csf barrier integrity by activating matrix metalloproteinases |
| topic |
General Neuroscience |
| url |
http://dx.doi.org/10.1523/jneurosci.0006-15.2015 |
| publishDate |
2015 |
| physical |
12766-12778 |
| description |
<jats:p>The blood–CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable molecules and pathogens into the brain. Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain. Recent research shows that Alzheimer's disease is associated with morphological changes in CPE cells and compromised production of CSF. Here, we studied the direct effects of Aβ on the functionality of the BCSFB. Intracerebroventricular injection of Aβ1–42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF. It also rapidly affected CPE cell morphology and tight junction protein levels. These changes were associated with loss of BCSFB integrity, as shown by an increase in BCSFB leakage. Aβ1–42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF. Interestingly, BCSFB disruption induced by Aβ1–42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice. These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1–42 oligomers. Our results reveal that Alzheimer's disease-associated soluble Aβ1–42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</jats:p><jats:p><jats:bold>SIGNIFICANCE STATEMENT</jats:bold>No treatments are yet available to cure Alzheimer's disease; however, soluble Aβ oligomers are believed to play a crucial role in the neuroinflammation that is observed in this disease. Here, we studied the effect of Aβ oligomers on the often neglected barrier between blood and brain, called the blood–CSF barrier (BCSFB). This BCSFB is formed by the choroid plexus epithelial cells and is important in maintaining brain homeostasis. We observed Aβ oligomer-induced changes in morphology and loss of BCSFB integrity that might play a role in Alzheimer's disease progression. Strikingly, both inhibition of matrix metalloproteinase (MMP) activity and MMP3 deficiency could protect against the detrimental effects of Aβ oligomer. Clearly, our results suggest that MMP inhibition might have therapeutic potential.</jats:p> |
| container_issue |
37 |
| container_start_page |
12766 |
| container_title |
The Journal of Neuroscience |
| container_volume |
35 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346266568491008 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:36:39.635Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Amyloid+%CE%B2+Oligomers+Disrupt+Blood%E2%80%93CSF+Barrier+Integrity+by+Activating+Matrix+Metalloproteinases&rft.date=2015-09-16&genre=article&issn=1529-2401&volume=35&issue=37&spage=12766&epage=12778&pages=12766-12778&jtitle=The+Journal+of+Neuroscience&atitle=Amyloid+%CE%B2+Oligomers+Disrupt+Blood%E2%80%93CSF+Barrier+Integrity+by+Activating+Matrix+Metalloproteinases&aulast=Vandenbroucke&aufirst=Roosmarijn+E.&rft_id=info%3Adoi%2F10.1523%2Fjneurosci.0006-15.2015&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346266568491008 |
| author | Brkic, Marjana, Balusu, Sriram, Van Wonterghem, Elien, Gorlé, Nina, Benilova, Iryna, Kremer, Anna, Van Hove, Inge, Moons, Lieve, De Strooper, Bart, Kanazir, Selma, Libert, Claude, Vandenbroucke, Roosmarijn E. |
| author_facet | Brkic, Marjana, Balusu, Sriram, Van Wonterghem, Elien, Gorlé, Nina, Benilova, Iryna, Kremer, Anna, Van Hove, Inge, Moons, Lieve, De Strooper, Bart, Kanazir, Selma, Libert, Claude, Vandenbroucke, Roosmarijn E., Brkic, Marjana, Balusu, Sriram, Van Wonterghem, Elien, Gorlé, Nina, Benilova, Iryna, Kremer, Anna, Van Hove, Inge, Moons, Lieve, De Strooper, Bart, Kanazir, Selma, Libert, Claude, Vandenbroucke, Roosmarijn E. |
| author_sort | brkic, marjana |
| container_issue | 37 |
| container_start_page | 12766 |
| container_title | The Journal of Neuroscience |
| container_volume | 35 |
| description | <jats:p>The blood–CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable molecules and pathogens into the brain. Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain. Recent research shows that Alzheimer's disease is associated with morphological changes in CPE cells and compromised production of CSF. Here, we studied the direct effects of Aβ on the functionality of the BCSFB. Intracerebroventricular injection of Aβ1–42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF. It also rapidly affected CPE cell morphology and tight junction protein levels. These changes were associated with loss of BCSFB integrity, as shown by an increase in BCSFB leakage. Aβ1–42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF. Interestingly, BCSFB disruption induced by Aβ1–42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice. These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1–42 oligomers. Our results reveal that Alzheimer's disease-associated soluble Aβ1–42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</jats:p><jats:p><jats:bold>SIGNIFICANCE STATEMENT</jats:bold>No treatments are yet available to cure Alzheimer's disease; however, soluble Aβ oligomers are believed to play a crucial role in the neuroinflammation that is observed in this disease. Here, we studied the effect of Aβ oligomers on the often neglected barrier between blood and brain, called the blood–CSF barrier (BCSFB). This BCSFB is formed by the choroid plexus epithelial cells and is important in maintaining brain homeostasis. We observed Aβ oligomer-induced changes in morphology and loss of BCSFB integrity that might play a role in Alzheimer's disease progression. Strikingly, both inhibition of matrix metalloproteinase (MMP) activity and MMP3 deficiency could protect against the detrimental effects of Aβ oligomer. Clearly, our results suggest that MMP inhibition might have therapeutic potential.</jats:p> |
| doi_str_mv | 10.1523/jneurosci.0006-15.2015 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTUyMy9qbmV1cm9zY2kuMDAwNi0xNS4yMDE1 |
| imprint | Society for Neuroscience, 2015 |
| imprint_str_mv | Society for Neuroscience, 2015 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0270-6474, 1529-2401 |
| issn_str_mv | 0270-6474, 1529-2401 |
| language | English |
| last_indexed | 2024-03-01T17:36:39.635Z |
| match_str | brkic2015amyloidboligomersdisruptbloodcsfbarrierintegritybyactivatingmatrixmetalloproteinases |
| mega_collection | Society for Neuroscience (CrossRef) |
| physical | 12766-12778 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | Society for Neuroscience |
| record_format | ai |
| recordtype | ai |
| series | The Journal of Neuroscience |
| source_id | 49 |
| spelling | Brkic, Marjana Balusu, Sriram Van Wonterghem, Elien Gorlé, Nina Benilova, Iryna Kremer, Anna Van Hove, Inge Moons, Lieve De Strooper, Bart Kanazir, Selma Libert, Claude Vandenbroucke, Roosmarijn E. 0270-6474 1529-2401 Society for Neuroscience General Neuroscience http://dx.doi.org/10.1523/jneurosci.0006-15.2015 <jats:p>The blood–CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable molecules and pathogens into the brain. Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain. Recent research shows that Alzheimer's disease is associated with morphological changes in CPE cells and compromised production of CSF. Here, we studied the direct effects of Aβ on the functionality of the BCSFB. Intracerebroventricular injection of Aβ1–42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF. It also rapidly affected CPE cell morphology and tight junction protein levels. These changes were associated with loss of BCSFB integrity, as shown by an increase in BCSFB leakage. Aβ1–42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF. Interestingly, BCSFB disruption induced by Aβ1–42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice. These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1–42 oligomers. Our results reveal that Alzheimer's disease-associated soluble Aβ1–42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</jats:p><jats:p><jats:bold>SIGNIFICANCE STATEMENT</jats:bold>No treatments are yet available to cure Alzheimer's disease; however, soluble Aβ oligomers are believed to play a crucial role in the neuroinflammation that is observed in this disease. Here, we studied the effect of Aβ oligomers on the often neglected barrier between blood and brain, called the blood–CSF barrier (BCSFB). This BCSFB is formed by the choroid plexus epithelial cells and is important in maintaining brain homeostasis. We observed Aβ oligomer-induced changes in morphology and loss of BCSFB integrity that might play a role in Alzheimer's disease progression. Strikingly, both inhibition of matrix metalloproteinase (MMP) activity and MMP3 deficiency could protect against the detrimental effects of Aβ oligomer. Clearly, our results suggest that MMP inhibition might have therapeutic potential.</jats:p> Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases The Journal of Neuroscience |
| spellingShingle | Brkic, Marjana, Balusu, Sriram, Van Wonterghem, Elien, Gorlé, Nina, Benilova, Iryna, Kremer, Anna, Van Hove, Inge, Moons, Lieve, De Strooper, Bart, Kanazir, Selma, Libert, Claude, Vandenbroucke, Roosmarijn E., The Journal of Neuroscience, Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases, General Neuroscience |
| title | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_full | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_fullStr | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_full_unstemmed | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_short | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| title_sort | amyloid β oligomers disrupt blood–csf barrier integrity by activating matrix metalloproteinases |
| title_unstemmed | Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases |
| topic | General Neuroscience |
| url | http://dx.doi.org/10.1523/jneurosci.0006-15.2015 |